Kenichiro Kiyoshima

Title: Kenichiro Kiyoshima: Innovator in Pharmaceutical Preparations

Introduction

Kenichiro Kiyoshima is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug preparations. With a total of 3 patents to his name, Kiyoshima's work focuses on enhancing the bioavailability and stability of therapeutic drugs.

Latest Patents

Kiyoshima's latest patents include a coated preparation that contains pioglitazone or a salt thereof as an active ingredient. This preparation demonstrates high bioavailability of pioglitazone and minimizes interindividual variation in blood drug concentration. Additionally, it features a core that contains a pharmaceutically acceptable organic acid with specific solubility and pK(a) characteristics. Another significant patent is for a solid preparation comprising alogliptin and pioglitazone, which is designed to be effective as a therapeutic drug for diabetes. This preparation is noted for its superior dissolution property, chemical stability, and dissolution stability.

Career Highlights

Kiyoshima is currently associated with Takeda Pharmaceutical Company Limited, a leading global pharmaceutical company. His work at Takeda has allowed him to focus on innovative drug formulations that address critical health issues.

Collaborations

Throughout his career, Kiyoshima has collaborated with esteemed colleagues, including Kenji Nakamura and Tetsuya Kawano. These collaborations have contributed to the advancement of pharmaceutical technologies and the development of effective drug preparations.

Conclusion

Kenichiro Kiyoshima's contributions to the pharmaceutical industry through his innovative patents highlight his commitment to improving drug efficacy and patient outcomes. His work continues to influence the field and pave the way for future advancements in pharmaceutical preparations.